SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 20.18% in the revenue at Rs. 1469.88 millions was reported in the September 2022 quarter as compared to Rs. 1223.08 millions during year-ago period.Profit saw a slight increase of 8.97%to Rs. 190.38  millions from Rs. 174.71 millions.Operating Profit saw a handsome growth to 289.79 millions from 275.34 millions in the quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1469.88 1223.08 20.18 2779.94 2354.38 18.08 5201.35 3406.08 52.71
Other Income 8.54 1.63 423.93 14.73 11.95 23.26 27.62 13.30 107.67
PBIDT 289.79 275.34 5.25 525.21 506.57 3.68 1079.38 815.32 32.39
Interest 4.49 26.92 -83.32 6.31 54.81 -88.49 64.07 56.18 14.04
PBDT 285.30 248.42 14.85 518.90 451.76 14.86 1015.31 759.14 33.74
Depreciation 28.19 23.18 21.61 58.57 45.45 28.87 100.80 41.88 140.69
PBT 257.11 225.24 14.15 460.33 406.31 13.30 914.51 717.26 27.50
TAX 66.73 50.53 32.06 121.32 94.36 28.57 195.04 177.27 10.02
Deferred Tax 6.21 7.06 -12.04 10.84 10.29 5.34 27.83 1.63 1607.36
PAT 190.38 174.71 8.97 339.01 311.95 8.67 719.47 539.99 33.24
Equity 364.37 364.37 0.00 364.37 364.37 0.00 364.37 315.00 15.67
PBIDTM(%) 19.72 22.51 -12.42 18.89 21.52 -12.19 20.75 23.94 -13.31

Acutaas Chemicals Share Price

2414.30 52.55 (2.23%)
20-Apr-2026 15:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1667.00
Dr. Reddys Lab 1231.15
Cipla 1227.30
Zydus Lifesciences 936.00
Lupin 2326.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×